A Population-Based Clinical Trial of Irinotecan and Carboplatin

Por Lau, Derick, Huynh, Minh, Johl, Jewel
Publicado em 2009

The Price of Remission

Por Al-Jazayrly, Ghassan, Lau, Derick H.M.
Publicado em 1997

LAS0811: From Combinatorial Chemistry to Activation of Antioxidant Response Element

Por Zhu, Ming, Baek, Hyounggee, Liu, Ruiwu, Song, Aimin, Lam, Kit, Lau, Derick
Publicado em 2009

Feasibility Study of Intra-patient Sorafenib Dose-Escalation or Re-Escalation in Patients with Previously Treated Advanced Solid Tumors

Por Semrad, Thomas J., Eddings, Courtney, Pan, Chong-Xian, Lau, Derick H., Gandara, David, Beckett, Laurel, Lara, Primo N.
Publicado em 2011

Phase II Trial of Irinotecan and Carboplatin for Extensive or Relapsed Small-Cell Lung Cancer

Por Chen, Gigi, Huynh, Minh, Fehrenbacher, Lou, West, Howard, Lara, Primo N., Yavorkovsky, Leonid L., Russin, Michael, Goldstein, Desiree, Gandara, David, Lau, Derick
Publicado em 2009

A Pilot Study (SWOG S0429) of Weekly Cetuximab and Chest Radiotherapy for Poor-Risk Stage III Non-Small Cell Lung Cancer

Por Chen, Yuhchyau, Moon, James, Pandya, Kishan J., Lau, Derick H. M., Kelly, Karen, Hirsch, Fred R., Gaspar, Laurie E., Redman, Mary, Gandara, David R.
Publicado em 2013

Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiothe...

Por Li, Baoqing, Li, Dan, Lau, Derick H, Farwell, D Gregory, Luu, Quang, Rocke, David M, Newman, Kathleen, Courquin, Jean, Purdy, James A, Chen, Allen M
Publicado em 2009

Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer

Por Ho, Cheryl, Davies, Angela M., Sangha, Randeep S., Lau, Derick, Lara, Primo, Chew, Helen K., Beckett, Laurel, Mack, Philip C., Riess, Jonathan W., Gandara, David R.
Publicado no Invest New Drugs (2013)

Intercalated Erlotinib-Docetaxel Dosing Schedules Designed to Achieve Pharmacodynamic Separation: Results of a Phase I/II Trial

Por Sangha, Randeep, Davies, Angela M., Lara, Primo N., Mack, Philip C., Beckett, Laurel A., Hesketh, Paul J., Lau, Derick, Li, Tianhong, Perkins, Natasha, Gandara, David R.
Publicado em 2011

Southwestern Oncology Group Phase II Trial (S0526) of Pemetrexed in Bronchioloalveolar Carcinoma Subtypes of Advanced Adenocarcinoma

Por Lau, Derick H.M., Moon, James, Davies, Angela M., Sanborn, Rachel E., Hirsch, Fred R., Franklin, Wilbur A., Ruzich, Janet C., Redman, Mary W., Gandara, David R.
Publicado no Clin Lung Cancer (2013)

Escalating weekly doses of cetuximab and correlation with skin toxicity: A phase I study

Por Ho, Cheryl, Sangha, Randeep, Beckett, Laurel, Tanaka, Michael, Lau, Derick H., Eisen, Daniel B., Burich, Rachel A., Luciw, Paul, Khan, Imran, Mack, Philip C., Gandara, David R., Davies, Angela M.
Publicado no Invest New Drugs (2010)

Randomized Phase II Trial of Concurrent Versus Sequential Bortezomib Plus Docetaxel in Advanced Non–Small-Cell Lung Cancer: A California Cancer Consortium Trial

Por Lara, Primo N., Longmate, Jeff, Reckamp, Karen, Gitlitz, Barbara, Argiris, Athanassios, Ramalingam, Suresh, Belani, Chandra P., Mack, Philip C., Lau, Derick H. M., Koczywas, Mariana, Wright, John J., Shepherd, Frances A., Leighl, Natasha, Gandara, David R.
Publicado em 2011

A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced stage solid cancers – A California C...

Por Chao, Joseph, Synold, Timothy W., Morgan, Robert J., Kunos, Charles, Longmate, Jeff, Lenz, Heinz-Josef, Lim, Dean, Shibata, Stephen, Chung, Vincent, Stoller, Ronald G., Belani, Chandra P., Gandara, David R., McNamara, Mark, Gitlitz, Barbara J., Lau, Derick H., Ramalingam, Suresh S., Davies, Angela, Espinoza-Delgado, Igor, Newman, Edward M., Yen, Yun
Publicado em 2011